European stocks rebound, oil prices ease after US-Iran volatility

Weather - Sydney 10°C

European stocks rebound, oil prices ease after US-Iran volatility

ECONOMY 20.02.2026

European stocks rebound, oil prices ease after US-Iran volatility / Photo: © US NAVY/AFP

European stocks rebounded and oil prices fell Friday as investors reassessed the chances of a US strike on Iran, after heightened geopolitical tensions sparked by President Donald Trump's threats amid talks on a nuclear deal.

Change text size:

It followed a weak session in Asia, where several markets remained closed for the Lunar New Year break.

Crude prices pulled back after climbing to six-month highs this week on worries that nuclear talks between the United States and oil-rich Iran might not avert a new conflict that could threaten supplies.

"Threats of military action against Iran from the Trump administration... created some jitters in the market yesterday -- with selling in US stocks being matched in most Asian markets," said AJ Bell investment director Russ Mould.

Trump warned Thursday that Tehran should make a "meaningful deal" in negotiations with Washington in the next 10 days or else "bad things happen".

Iran warned that US bases, facilities and assets would be "legitimate targets" if its followed through on its military threats and attacks.

The threats come days after the United States and Iran held a second round of talks in Geneva as Washington looks to prevent the country from getting a nuclear bomb, which Tehran says it is not pursuing.

"At its core, this looks like pressure and leverage rather than a prelude to invasion," said City Index market analyst Matt Simpson.

On stock markets, Hong Kong fell as it reopened from a three-day break, and Tokyo was also down.

London, Paris and Frankfurt all advanced in midday trading.

A closely watched survey on Friday showed that business activity in the eurozone accelerated in February, indicating that the region's economy is on more stable footing.

British firms also boosted output in February, according to the purchasing managers' index published by S&P Global.

Traders are looking ahead to the release of US data later in the day that will provide a fresh snapshot of the world's biggest economy.

A slew of forecast-beating figures over the past days has lifted optimism about the outlook but tempered expectations for more interest rate cuts from the Federal Reserve.

Shares in Jakarta slipped after Trump and Indonesian President Prabowo Subianto reached a trade deal after months of wrangling.

The accord sets a 19 percent tariff on Indonesian goods entering the United States, below potential 32 percent levy the the Southeast Asian country had been threatened with.

Jakarta also agreed to $33 billion in purchases of US energy commodities, agricultural products and aviation-related goods, including Boeing aircraft.

- Key figures at around 1120 GMT -

London - FTSE 100: UP 0.3 percent at 10,694.40 points

Paris - CAC 40: UP 0.8 percent at 8,463.84

Frankfurt - DAX: UP 0.3 percent at 25,111.12

Tokyo - Nikkei 225: DOWN 1.1 percent at 56,825.70 (close)

Hong Kong - Hang Seng Index: DOWN 1.1 percent at 26,413.35 (close)

Shanghai - Composite: Closed for holiday

New York - Dow: DOWN 0.5 percent at 49,395.16 (close)

Euro/dollar: DOWN at $1.1766 from $1.1767 on Thursday

Pound/dollar: UP at $1.3474 from $1.3458

Euro/pound: DOWN at 87.34 pence from 87.43 pence

Dollar/yen: UP at 155.23 yen from 155.07 yen

Brent North Sea Crude: DOWN 0.5 percent at $71.34 per barrel

West Texas Intermediate: DOWN 0.5 percent at $66.06 per barrel

E.Reid--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - European stocks rebound, oil prices ease after US-Iran volatility